U.S. markets open in 1 hour

Revolution Medicines, Inc. (RVMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
43.25-0.52 (-1.19%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
46,320
50,041
20,165
0
Operating Expense
142,501
104,161
60,494
31,129
Operating Income
-96,181
-54,120
-40,329
-31,129
Net Non Operating Interest Income Expense
2,524
2,083
661
2
Other Income Expense
-
-
-2,121
-
Pretax Income
-93,657
-52,037
-41,789
-31,127
Tax Provision
-5,106
-4,373
-
0
Net Income Common Stockholders
-95,021
-61,902
-39,668
-34,890
Diluted NI Available to Com Stockholders
-95,021
-61,902
-39,668
-34,890
Basic EPS
-
-0.0012
-0.0017
0
Diluted EPS
-
-0.0012
-0.0017
0
Basic Average Shares
-
52,902
23,163
36,473
Diluted Average Shares
-
52,902
23,163
36,473
Total Operating Income as Reported
-96,181
-54,120
-40,329
-31,129
Total Expenses
142,501
104,161
60,494
31,129
Net Income from Continuing & Discontinued Operation
-88,551
-47,664
-41,789
-31,127
Normalized Income
-88,551
-47,664
-41,789
-31,127
Interest Income
2,604
2,189
777
105
Interest Expense
80
106
116
103
Net Interest Income
2,524
2,083
661
2
EBIT
-93,577
-51,931
-41,673
-31,024
EBITDA
-87,867
-
-
-
Reconciled Depreciation
5,710
3,342
1,764
1,188
Net Income from Continuing Operation Net Minority Interest
-88,551
-47,664
-41,789
-31,127
Normalized EBITDA
-87,867
-48,589
-39,909
-29,836
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0